[CLSTR]
< Back to situations

[ORGANIZATION]

MSD

Featured in 19 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [ES] [US]

mRNA technology and personalized cancer vaccine research

2 clusters · 30 sources · last updated

Latest: Moderna and Merck trial results show mRNA melanoma vaccine reduces recurrence risk

Recent medical research highlights significant progress in using messenger RNA (mRNA) technology to develop personalized cancer vaccines. These vaccines utilize a patient’s specific tumor mutations or neoantigens to trai

[ACTIVE] [HEALTH] [DE] [IT] [ES]

Daraxonrasib development for pancreatic cancer

3 clusters · 57 sources · last updated

Latest: ESMO 2026 Congress reveals major breakthroughs in cancer immunotherapy

In September 2026, Felice Antonio Spaccavento, a health official in the Puglia region of Italy, formally requested that the Italian Medicines Agency (AIFA) accelerate access to the targeted therapy daraxonrasib. The requ

[ACTIVE] [BUSINESS] [US] [CN] [ES]

Moderna and Merck melanoma vaccine clinical trials

18 clusters · 555 sources · last updated

Latest: Moderna and Merck cancer vaccine reduces melanoma recurrence risk by 42%

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (V940), an experimental personalized mRNA cancer vaccine. The INTerpath-001 trial, which administered the vaccine alon

[ACTIVE] [HEALTH] [EU] [IS] [KR]

Keytruda therapeutic expansions and approvals

2 clusters · 24 sources · last updated

Latest: European Commission approves bladder cancer treatment

The immunotherapy drug Keytruda has seen recent developments regarding new formulations and expanded clinical applications. In South Korea, MSD Korea announced the October launch of a subcutaneous (SC) formulation of Ke

[ACTIVE] [HEALTH] [GH] [BT] [BW]

Ghana healthcare infrastructure and resource challenges

12 clusters · 22 sources · last updated

Latest: Ghana's Savannah Region launches HPV vaccination catch-up drive

Ghana is significantly expanding its healthcare reach through the Free Primary Healthcare (FPHC) programme, which is now operational in 135 districts. To support this community-focused shift, Health Minister Kwabena Mint

[QUIET] [HEALTH] [KE] [LR] [NG]

HPV vaccination efforts in Nigeria

2 clusters · 8 sources · last updated

Latest: Nigeria vaccinates 18 million girls against HPV

Nigeria has vaccinated more than 18 million adolescent girls against the Human Papillomavirus (HPV), reaching roughly 76 per cent of its target population. This initiative follows the inclusion of the HPV vaccine in the

Also covered in